Lapatinib Completed Phase 2 Trials for Glioblastoma Multiforme (GBM) / Neoplasms, Brain / GS / Gliomas / Gliosarcoma / GBM Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00107003GW572016 to Treat Recurrent Malignant Brain Tumors
NCT00350727Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma